Drugs / Cimicoxib
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT00510822 | Oct 2007 → Feb 2010 | major depressive disorder | Affectis Pharmaceuticals AG | Completed | No outcome recorded |
Evidence & citations 7 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Cimicoxib | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00510822 ↗ |
| Known as | Cimalgex | ChEMBL registry synonym — accepted as the source's own label CHEMBL435381 ↗ |
| Known as | Cimicoxib (ema epar: veterinary) | ChEMBL registry synonym — accepted as the source's own label CHEMBL435381 ↗ |
| Known as | UR-8880 | ChEMBL registry synonym — accepted as the source's own label CHEMBL435381 ↗ |
| Action | Inhibit | “a selective COX-2 inhibitor” NCT00510822 ↗1“Cyclooxygenase-2 inhibitor” CHEMBL435381 ↗ |
| Modality | Small molecule | — CHEMBL435381 ↗ |
| Target | PTGS2 | “Cyclooxygenase-2 inhibitor” CHEMBL435381 ↗ |